Track-and-trace bill set for consideration in House

06/2/2013 | Hill, The

The House of Representatives is expected to pass a bill that would require drug manufacturers, repackagers and distributors to devise a mechanism to trace pharmaceuticals back to their source in an effort to fight counterfeit production. "It is of utmost importance that we implement common-sense solutions to safeguard our distribution supply chain against counterfeits and improve security and integrity throughout the supply chain," said Rep. Bob Latta, R-Ohio, who sponsored the measure.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Health Plan Administration, Payor Relations and Contracting
St. Charles Health System
Bend, OR
Compliance Sr Mgr
Thousand Oaks, CA
Senior Counsel, Regulatory (FDA)
San Diego , CA
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA